适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- one
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Klinefelter or Turner syndrome as confirmed by genetic testing - Sufficient knowledge of the Dutch language to complete the questionnaires - At least 18 years old
排除标准
- •- KS: Patients not under treatment in the EMC or VUmc or no planned visits during the study period - TS: No laboratory values or no questionnaires available in patient records - Severe psychiatric or neurologic disorders or other reasons for inability to complete the questionnaires as assessed by the treating physician. - Failure to obtain informed consent
研究者
相似试验
尚未招募
不适用
Turner And Klinefelter Treatment Target studyKlinefelter syndrome (KS)monosomy XTurner syndroom (TS)XXY syndrome100836241001470110018515NL-OMON45826Erasmus MC, Universitair Medisch Centrum Rotterdam350
尚未招募
不适用
Cognitive effects for changes in appearance due to orthognathic surgeryJaw deformityJPRN-UMIN000046742Showa University20
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40
招募中
不适用
A study to optimize the dose of sunitinib based on blood levels of the drug and its metabolite in kidney cancerCTRI/2020/03/023900Advanced Cancer for Treatment Research and Education